GELS (Gelteq) EV-to-OCF: (As of Aug. 13, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GELS Gelteq Ltd GELS
9 GF Score
Price $0.59
! 4 Warning Signs
View Full Analysis

What is Gelteq EV-to-OCF?

EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Gelteq's Enterprise Value is $9.90 Mil. Gelteq's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil. Therefore, Gelteq's EV-to-OCF for today is .

The historical rank and industry rank for Gelteq's EV-to-OCF or its related term are showing as below:

GELS' s EV-to-OCF Range Over the Past 10 Years
Min: -23.58   Med: -4.04   Max: -1.79
Current: -2.75

During the past 6 years, the highest EV-to-OCF of Gelteq was -1.79. The lowest was -23.58. And the median was -4.04.

GELS's EV-to-OCF is ranked better than
74.65% of 1006 companies
in the Drug Manufacturers industry
Industry Median: 11.145 vs GELS: -2.75

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-08-13), Gelteq's stock price is $0.5882. Gelteq's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.449. Therefore, Gelteq's PE Ratio (TTM) for today is At Loss.

Gelteq  (NAS:GELS) EV-to-OCF Explanation

EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Gelteq's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.5882/-0.449
=At Loss

Gelteq's share price for today is $0.5882.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gelteq's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.449.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Gelteq EV-to-OCF Related Terms

Gelteq EV-to-OCF Historical Data

* Premium members only.

The historical data trend for Gelteq's EV-to-OCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelteq EV-to-OCF Chart

Gelteq Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
EV-to-OCF
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -5.53

Gelteq Semi-Annual Data
Jun20 Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EV-to-OCF Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -5.53 0.00

GELS vs APUS, INM, YCBD: EV-to-OCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Gelteq's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gelteq EV-to-OCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gelteq's EV-to-OCF distribution charts can be found below:

* The bar in red indicates where Gelteq's EV-to-OCF falls into.


GELS
9GF Score
Gelteq Ltd GELS
EV-to-OCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gelteq EV-to-OCF Calculation

Gelteq's EV-to-OCF for today is calculated as:

EV-to-OCF=Enterprise Value (Today)/Cash Flow from Operations (TTM)
=9.902/0
=

Gelteq's current Enterprise Value is $9.90 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gelteq's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gelteq Business Description

Address 644 Chapel Street, Level 19, South Yarra, VIC, AUS, 3141
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
9GF Score

Get the complete analysis for GELS

EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.59
Price